Risk Factors Update Summary
- OECD proposed a global minimum tax rate of 15%, effective after Jan 1, 2024, with potential impacts on operations.
- New governmental regulations or changes in existing regulations may reduce demand for products. The Inflation Reduction Act of 2022 could impact drug prices.
- Increased FDA regulation of laboratory-developed tests may delay commercialization and add costs.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=97745&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.